The Effectivity of Combination of Standard Interferon-alpha

被引:0
|
作者
Ozgunes, Nail [1 ]
Sargin, Fatma [1 ]
Yazici, Saadet [1 ]
Ceylan, Nuket [1 ]
Ucisik, Ayse Canan [1 ]
Ergen, Pinar [1 ]
Dogru, Arzu [1 ]
Aydin, Ozlem [1 ]
机构
[1] SB Goztepe Egitim & Arastirma Hastartesi, Infeks Elastaliklan & Klin Mikrobiyol Klin, Istanbul, Turkey
来源
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL | 2006年 / 11卷 / 02期
关键词
Chronic hepatitis C; interferon alpha; pegylated interferon alpha; ribavirin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was done in order to evaluate the effectivity of combination therapy of standard interferon alpha (IFN-alpha) + ribavirin and pegylated IFN-alpha (PEG-IFN-alpha) + ribavirin in patients with chronic hepatitis C between 2003-2005 years in our clinic. Totally 52 patients were included in the study. In the combination treatment protocols, standard IFN-alpha 2 alpha or 2b plus ribavirin was given in 35 patients (group I) and PEG-IFN-a plus ribavirin in 17 patients (group II). Duration of treatment was 12 months. Rate of biochemical and virological responses at the end of the therapy and sustained response were 66.6%, 78.7%, 57.7% in group I and 71.4%, 85%, 66.7% in group II, respectively In conclusion, treatment protocols was effective in both groups and the rate of biochemical and virologic responses at the end of the therapy and sustained response were higher in group II than group I but the differences between groups were not significant. In according to the results of this study; PEG-IFN should be preferred to standard IFN-alpha.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 50 条
  • [21] Investigation of an anticancer activity of combination of interferon-alpha and gemcitabine on pancreatic cancer cells
    Isayev, Orkhan
    Sokolova, Darina V.
    Anisimova, Natalia Yu
    Spirina, Tatiana S.
    Gasimov, Eldar
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (05) : 1494 - 1498
  • [22] INTERFERON-ALPHA RETREATMENT IN CHRONIC HEPATITIS-C
    GERKEN, G
    TEUBER, G
    GOERGEN, B
    HERMANN, K
    ZUMBUSCHENFELDE, KHM
    JOURNAL OF HEPATOLOGY, 1995, 22 : 118 - 121
  • [23] Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Hoffmann, RM
    Leifeld, L
    Lafrenz, M
    Spengler, U
    Pape, GR
    Hopf, U
    Zeuzem, S
    DIGESTION, 2000, 61 (02) : 90 - 97
  • [24] Interferon-alpha and hepatitis C virus: the skin matters
    Floristan, U.
    Feltes, R.
    Ramirez-Marin, P.
    Herranz-Pinto, P.
    REVISTA CLINICA ESPANOLA, 2011, 211 (02): : 92 - 97
  • [25] IMMUNOLOCALIZATION OF INTERFERON-ALPHA IN HEPATITIS-C PATIENTS AND ITS CORRELATION WITH RESPONSE TO INTERFERON-ALPHA THERAPY
    GREENWAY, AL
    HERTZOG, PJ
    DEVENISH, RJ
    DUDLEY, FJ
    MCMULLEN, GL
    LINNANE, AW
    JOURNAL OF HEPATOLOGY, 1994, 21 (05) : 842 - 852
  • [26] Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial
    Kiso, S
    Kawata, S
    Tamura, S
    Imai, Y
    Inui, Y
    Nagase, T
    Maeda, Y
    Yamasaki, E
    Tsushima, H
    Igura, T
    Himeno, S
    Seki, K
    Matsuzawa, Y
    JOURNAL OF GASTROENTEROLOGY, 1997, 32 (01) : 56 - 62
  • [27] OFUJI PAPULOERYTHRODERMA - RESPONSE TO INTERFERON-ALPHA
    PLANTIN, P
    MILOCHAU, P
    LEROY, JP
    BERTHOU, C
    SENSEBE, L
    ABGRALL, JF
    GUILLET, G
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1992, 119 (09): : 643 - 645
  • [28] THE OPIOID MECHANISM OF INTERFERON-ALPHA ACTION
    HO, BT
    LU, JG
    HUO, YY
    FAN, SH
    MEYERS, CA
    TANSEY, LW
    PAYNE, R
    LEVIN, VA
    ANTI-CANCER DRUGS, 1994, 5 (01) : 90 - 94
  • [29] An Early Viral Response to Standard Interferon-Alpha Identifies Resistance to Combination Therapy With Peginterferon and Ribavirin in Patients Infected by HCV Genotype 1
    Toyoda, Hidenori
    Kumada, Takashi
    Kiriyama, Seiki
    Tanikawa, Makoto
    Hisanaga, Yasuhiro
    Kanamori, Akira
    Tada, Toshifumi
    Takagi, Makiko
    Hiramatsu, Takeshi
    Hosokawa, Takanori
    Arakawa, Takahiro
    Fujimori, Masashi
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (09) : 1537 - 1544
  • [30] Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine
    Kinouchi, T
    Saiki, S
    Maeda, O
    Kuroda, M
    Usami, M
    Kotake, T
    JOURNAL OF UROLOGY, 1997, 157 (05) : 1604 - 1607